The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance
Review
[키워드] accelerated
acute respiratory syndrome
animal model
Antiviral
approved
Black Death
Carboxylesterases
caused
cellular
Clinical sign
Concentration
coronavirus
Coronavirus disease 2019
COVID-19
COVID-19 pandemic
Critical
cross
deaths
demonstrated
drug
Drug-drug interactions, interspecies difference
Ebola
Efficacy
Efficacy and safety
example
food
hydrolysis
IMPROVE
in vitro
increase
intravenously
Mortality
notable
pandemic
Pandemics
parameter
preclinical studies
Randomized controlled trial
Remdesivir
SARS-CoV-2
Seven
Spanish
spike
the United State
therapeutic
therapeutic option
Toxicity
treating COVID-19
Treatment
Vaccines
viral disease
virus
viruses
[DOI] 10.1186/s44149-021-00017-5 PMC 바로가기 [Article Type] Review
[DOI] 10.1186/s44149-021-00017-5 PMC 바로가기 [Article Type] Review